Stratview Research has launched a new report, titled Heart Blocks Treatment Devices Market, By Type (First-Degree Heart Block, Second-Degree Heart Block, Third-Degree Heart Block), By Product (Transcutaneous Pacing, Pacemaker, Mediation, Follow-up Electrophysiology Study), By End User (Hospital Testing, Home treatment, Clinics, Others) and Region.
Covid-19 Impact Analysis:
Covid-19 has highly impacted the market dynamics, competition, and supply chain of almost all industries. The revenues have gone down in 2020 and are expected to resume an uptrend gradually from 2021 and continue to grow further. The report covers all the segments that were affected by the pandemic.
is estimated to grow from USD 2.8 billion in 2020 to USD 3.8 billion by 2026 at a healthy CAGR of 5.4% during the forecast period.
Market Segments' Analysis
Based on Product, the market has been classified into transcutaneous pacing, pacemaker, mediation, and follow-up electrophysiology study. The pacemaker segment accounted for a substantial market share in 2020. Growing incidences of Cardiovascular Diseases (CVDs), increasing cost of cardiac disease management, favorable government policies, and the emergence of technologically advanced pacemakers such as leadless pacemakers and MRI safe pacemakers, further bolster the segment growth.
The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the strong presence of well-developed healthcare infrastructure, increasing investment in R&D activities, higher adoption of these technologies, and favorable government initiatives. Moreover, the favorable reimbursement policies, high rate of R&D activities, easy availability of advanced technology, and enhanced patient knowledge within the region, further proliferates the regional growth.
The following are the key players in the Heart Blocks Treatment Devices Market.
· Medtronic (US)
· Abbott (US)
· MicroPort Scientific Corporation (China)
· Koninklijke Philips N.V. (Netherlands)
· Boston Scientific Corporation (US)
· LivaNova PLC (UK)
· Lepu Medical Technology (Beijing) Co., Ltd. (China)
· McKesson Corporation
· SCHILLER (Switzerland)
Frequently Asked Questions –
This report provides vital information and valuable insights, enabling the users to identify the strategic growth opportunities in the market. The report aims at answering the following key questions:
- What is the current and future market size of Heart Blocks Treatment Devices Market?
- How has the COVID-19 pandemic impacted the market? How fast is it expected to recover?
- What will be the short and long-term effects of the pandemic?
- How are other market factors affecting the market dynamics?
- Which segments offer high-growth opportunities in the long run?
- How fierce is the Heart Blocks Treatment Devices Market competition?
- What are the key emerging trends and unmet needs in the present market?
- What are the strategic growth opportunities and key success factors?
Custom Research: Stratview Research offers custom research services across the sectors. In case of any custom research requirement or any further query related to the report, please send your inquiry to
. You may also connect with our market experts at +1-313-307-4176.
About Stratview Research
Stratview Research is a global market research firm that provides high-quality market research reports, market entry strategies, growth strategies, and more. We in-depth market research studies, to help the users obtain grainy level clarity on present business trends and probable future developments. At Stratview Research, the market experts are committed to providing custom solutions best fit for strategy development and implementation to achieve visible growth.